Posts

Psychedelic Business Spotlight: November 5
Business, Stock ReportsThis week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.

Revive Therapeutics Is Exploring This Mushroom’s Potential to Treat Aggressive Breast Cancer
Research, TreatmentThe company is also pursuing psilocybin as a possible treatment for rare cancers, but they see huge potential in researching the medicinal effects of the reishi mushroom.